Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists

Intravenous magnesium sulphate allows safer intravenous β(2)-agonist delivery in acute-severe and life-threatening asthma attacks https://bit.ly/3veUpfC

Detalles Bibliográficos
Autores principales: Sellers, William F.S., James, Michael F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584576/
https://www.ncbi.nlm.nih.gov/pubmed/36338248
http://dx.doi.org/10.1183/20734735.0015-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584576/
https://www.ncbi.nlm.nih.gov/pubmed/36338248
http://dx.doi.org/10.1183/20734735.0015-2022

Ejemplares similares